GlassScriptPhysician profile
Ewa B Bak
NPI 1336185339
$4,554.89
in general payments reported to CMS, 2019-2025
47 companies · $1,039 in 2025
The $1,039 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $88.73 · 2021: $15.81 · 2022: $571 · 2023: $1,003 · 2024: $1,445 · 2025: $1,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,487.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $458.31 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $387.53 | 2019-2025 | Vraylar, Linzess, Viberzi |
| Pfizer INC. | $328.90 | 2019-2025 | |
| Amgen INC. | $281.04 | 2019-2025 | Evenity, Repatha, Otezla |
| Novo Nordisk INC | $262.08 | 2019-2025 | Rybelsus, Ozempic |
| Heartflow, INC. | $252.51 | 2024 | |
| Abbott Laboratories | $220.47 | 2020-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $208.02 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $186.55 | 2019-2025 | Eliquis |
| Lilly USA, LLC | $164.00 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Astellas Pharma US INC | $156.11 | 2019-2025 | Veozah |
| Stryker Corporation | $150.07 | 2024 | Actishield |
| Merck Sharp & Dohme LLC | $135.64 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Xeris Pharmaceuticals, INC. | $128.69 | 2023-2024 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $123.88 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ewa Bak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.